The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of camrelizumab combined with apatinib in previously treated recurrent or metastatic nasopharyngeal carcinoma: A phase II clinical trial.
 
Lin-Quan Tang
No Relationships to Disclose
 
Guo-Dong Jia
No Relationships to Disclose
 
xiao-Fei Lv
No Relationships to Disclose
 
Siyi Xie
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose
 
Ji-Bin Li
No Relationships to Disclose
 
Xiao Yun Li
No Relationships to Disclose
 
Manyi Zhu
No Relationships to Disclose
 
Sai Lan Liu
No Relationships to Disclose
 
LiTing Liu
No Relationships to Disclose
 
Xue-Song Sun
No Relationships to Disclose
 
Shanshan Guo
No Relationships to Disclose
 
Dong-Hua Luo
No Relationships to Disclose
 
Qiu-Yan Chen
No Relationships to Disclose
 
Hai-Qiang Mai
No Relationships to Disclose